L1TD1 and non-small cell lung carcinoma: DNMT inhibitor treatment of non-small cell lung carcinoma (NSCLC) patient-derived cells resulted in reduced cell viability and up-regulation of L1TD1, indicating an epigenetic control of the L1TD1 gene (Altenberger et al., 2017).